دورية أكاديمية
Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis.
العنوان: | Racial/Ethnic Disparities in Telemedicine Utilization and Satisfaction Among Breast Cancer Patients During the COVID-19 Pandemic: A Mixed-Methods Analysis. |
---|---|
المؤلفون: | Freeman JQ; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois, USA., Khwaja A; Department of Medicine, The University of Chicago, Chicago, Illinois, USA., Zhao F; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois, USA., Nanda R; Department of Medicine, The University of Chicago, Chicago, Illinois, USA., Olopade OI; Department of Medicine, The University of Chicago, Chicago, Illinois, USA.; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois, USA., Huo D; Department of Public Health Sciences, The University of Chicago, Chicago, Illinois, USA.; Center for Clinical Cancer Genetics and Global Health, The University of Chicago, Chicago, Illinois, USA. |
المصدر: | Telemedicine journal and e-health : the official journal of the American Telemedicine Association [Telemed J E Health] 2024 Mar; Vol. 30 (3), pp. 651-663. Date of Electronic Publication: 2023 Sep 07. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100959949 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-3669 (Electronic) Linking ISSN: 15305627 NLM ISO Abbreviation: Telemed J E Health Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Larchmont, NY : Mary Ann Liebert, Inc., c2000- |
مواضيع طبية MeSH: | Breast Neoplasms*/therapy , Breast Neoplasms*/diagnosis , COVID-19*/epidemiology , Telemedicine*, Female ; Humans ; Black or African American ; Healthcare Disparities ; Longitudinal Studies ; Pandemics ; Patient Satisfaction ; Personal Satisfaction ; White People ; Hispanic or Latino ; White |
مستخلص: | Background: Telemedicine has expanded rapidly during the COVID-19 pandemic. Data on telemedicine utilization are lacking, and racial/ethnic disparities in utilization and satisfaction are unknown among breast cancer patients. Methods: This was a longitudinal study, with two surveys conducted in 2020 and 2021, among patients enrolled in the Chicago Multiethnic Epidemiologic Breast Cancer Cohort. Telemedicine utilization was modeled using mixed-effects logistic regression. Telemedicine satisfaction, assessed using a 5-point Likert scale, was modeled using mixed-effects proportional odds regression. Qualitative data on satisfaction were coded and analyzed using grounded theory. Results: Of 1,721 respondents, most (70.3%) were White, followed by 23.6% Black, 3.1% Asian, and 3.0% Hispanic. The median duration from breast cancer diagnosis to survey was 5.5 years (interquartile range: 2.7-9.4). In 2020, 59.2% reported telemedicine use; in 2021, 64.9% did, with a statistically significant increase ( p < 0.001). Black patients had greater odds of telemedicine use than White patients (adjusted odds ratio [AOR] = 1.55, 95% confidence interval [CI]: 1.17-2.05). In 2020, 90.3% reported somewhat-to-extreme satisfaction; in 2021, 91.2% did, with a statistically significant, although clinically small, increase ( p = 0.038). There were no racial/ethnic differences in telemedicine satisfaction between Black (AOR = 1.05, 95% CI: 0.81-1.35), Asian (AOR = 0.63, 95% CI: 0.34-1.16), or Hispanic (AOR = 0.63, 95% CI: 0.33-1.21) and White patients. Major themes emerged from the respondents that explained their levels of satisfaction were convenience, safety, specialty dependence, and technical issues. Conclusions: Telemedicine utilization and satisfaction were high among breast cancer patients over time and across races/ethnicities. Telemedicine could have great potential in reducing barriers to care and promoting health equity for breast cancer patients. However, patients' perceived challenges in accessing high-quality virtual care should be addressed. |
References: | JAMA. 2016 May 10;315(18):2015-6. (PMID: 27163991) J Clin Epidemiol. 1992 Jun;45(6):613-9. (PMID: 1607900) PM R. 2021 Dec;13(12):1362-1368. (PMID: 33455066) J Natl Compr Canc Netw. 2020 Sep 30;:1-7. (PMID: 32998106) Ann Surg Oncol. 2022 Apr;29(4):2244-2252. (PMID: 34820744) Am J Surg. 2019 Sep;218(3):476-479. (PMID: 30253859) Future Oncol. 2021 Aug;17(23):3077-3085. (PMID: 34102878) Breast Cancer Res Treat. 2021 Feb;185(3):841-849. (PMID: 33111220) J Am Med Inform Assoc. 2021 Jan 15;28(1):119-125. (PMID: 32894772) Oncologist. 2021 Mar;26(3):e512-e515. (PMID: 33094533) JCO Oncol Pract. 2021 Sep;17(9):e1327-e1332. (PMID: 34152833) J Surg Oncol. 2021 Feb;123(2):371-374. (PMID: 33333581) Cancer Med. 2022 Feb;11(4):1192-1201. (PMID: 34989148) MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1595-1599. (PMID: 33119561) NCHS Data Brief. 2022 Oct;(445):1-8. (PMID: 36255940) JCO Oncol Pract. 2021 Sep;17(9):546-564. (PMID: 34319760) Ann Surg Oncol. 2021 Oct;28(10):5668-5676. (PMID: 34275045) JAMA. 2018 Nov 27;320(20):2147-2149. (PMID: 30480716) J Breast Cancer. 2020 Oct 19;23(5):542-552. (PMID: 33154829) J Natl Compr Canc Netw. 2021 Jan 4;19(10):1174-1180. (PMID: 33395627) JAMA Oncol. 2020 Nov 1;6(11):1698-1699. (PMID: 32672821) JAMA Netw Open. 2020 Jun 1;3(6):e205873. (PMID: 32585018) Br J Cancer. 2021 Nov;125(11):1486-1493. (PMID: 34588616) |
معلومات مُعتمدة: | P20 CA233307 United States CA NCI NIH HHS |
فهرسة مساهمة: | Keywords: breast cancer; racial/ethnic disparities; satisfaction; telemedicine; utilization |
تواريخ الأحداث: | Date Created: 20230907 Date Completed: 20240311 Latest Revision: 20240417 |
رمز التحديث: | 20240417 |
مُعرف محوري في PubMed: | PMC10924050 |
DOI: | 10.1089/tmj.2023.0225 |
PMID: | 37676974 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1556-3669 |
---|---|
DOI: | 10.1089/tmj.2023.0225 |